Purchases and Sales Made in Q2 2024 in Nls Pharmaceutics Ltd. (NLSP)
This table provides information about the institutional ownership of Nls Pharmaceutics Ltd. (NLSP) during Q2 2024. The information is specifically focused on institutions that hold shares of NLS Pharmaceutics Ltd..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 13, 2024
Q2 2024
|
Ubs Group Ag
|
BUY
|
- |
236KNew |
$25.9K - $63.6K
|
236K
$446K
|
|
|
Aug 14, 2024
Q2 2024
|
Armistice Capital, LLC
New York, NY |
BUY
|
- |
139K+ 6.4% |
$15.3K - $37.5K
|
2.31M
$4.37M
|
|
|
Aug 14, 2024
Q2 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
117K+ 610.37% |
$12.9K - $31.6K
|
136K
$258K
|
|
|
Aug 14, 2024
Q2 2024
|
Jane Street Group, LLC
New York, NY |
BUY
|
- |
43.7KNew |
$4.8K - $11.8K
|
43.7K
$82.5K
|
|
|
Aug 12, 2024
Q2 2024
|
Hrt Financial LP
New York, NY |
BUY
|
- |
16.8KNew |
$1.85K - $4.54K
|
16.8K
$31.8K
|
|
|
Jul 23, 2024
Q2 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 09, 2024
Q2 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-158K- 87.87% |
$17.4K - $42.6K
|
21.8K
$41.2K
|